These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 21593785)

  • 1. Assessing the risk of second malignancies after modern radiotherapy.
    Newhauser WD; Durante M
    Nat Rev Cancer; 2011 Jun; 11(6):438-48. PubMed ID: 21593785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of radiation quality on the risks of second malignancies.
    Manem VS; Kohandel M; Hodgson DC; Sharpe MB; Sivaloganathan S
    Int J Radiat Biol; 2015 Mar; 91(3):209-17. PubMed ID: 25356906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic radiation and the potential risk of second malignancies.
    Kamran SC; Berrington de Gonzalez A; Ng A; Haas-Kogan D; Viswanathan AN
    Cancer; 2016 Jun; 122(12):1809-21. PubMed ID: 26950597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation burden from secondary doses to patients undergoing radiation therapy with photons and light ions and radiation doses from imaging modalities.
    Gudowska I; Ardenfors O; Toma-Dasu I; Dasu A
    Radiat Prot Dosimetry; 2014 Oct; 161(1-4):357-62. PubMed ID: 24353029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B
    J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
    Acharya S; Sarafoglou K; LaQuaglia M; Lindsley S; Gerald W; Wollner N; Tan C; Sklar C
    Cancer; 2003 May; 97(10):2397-403. PubMed ID: 12733137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study.
    Teepen JC; Kok JL; Kremer LC; Tissing WJE; van den Heuvel-Eibrink MM; Loonen JJ; Bresters D; van der Pal HJ; Versluys B; van Dulmen-den Broeder E; Nijsten T; Hauptmann M; Hollema N; Dolsma WV; van Leeuwen FE; Ronckers CM;
    J Natl Cancer Inst; 2019 Aug; 111(8):845-853. PubMed ID: 30802904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
    Simone CB; Kramer K; O'Meara WP; Bekelman JE; Belard A; McDonough J; O'Connell J
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):242-9. PubMed ID: 21236595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Special radiobiological features of second cancer risk after particle radiotherapy.
    Trott KR
    Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 20th Gray lecture 2019: health and heavy ions.
    Blakely EA
    Br J Radiol; 2020 Nov; 93(1115):20200172. PubMed ID: 33021811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abscopal Effect: Propitious or Pernicious?
    Sarode SC; Maniyar N; Sarode GS; Patil S
    J Contemp Dent Pract; 2017 May; 18(5):349-351. PubMed ID: 28512270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photons or protons for non-central nervous system solid malignancies in children: a historical perspective and important highlights.
    Daw NC; Mahajan A
    Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models for the risk of secondary cancers from radiation therapy.
    Dasu A; Toma-Dasu I
    Phys Med; 2017 Oct; 42():232-238. PubMed ID: 28242139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the biology of heavy-ion cancer therapy.
    Hamada N; Imaoka T; Masunaga S; Ogata T; Okayasu R; Takahashi A; Kato TA; Kobayashi Y; Ohnishi T; Ono K; Shimada Y; Teshima T
    J Radiat Res; 2010; 51(4):365-83. PubMed ID: 20679739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
    Palm A; Johansson KA
    Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment for cancer induction after low- and high-LET therapeutic irradiation.
    Engels H; Menzel HG; Pihet P; Wambersie A
    Strahlenther Onkol; 1999 Jun; 175 Suppl 2():47-51. PubMed ID: 10394397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second neoplasms following megavoltage radiation in a pediatric population.
    Haselow RE; Nesbit M; Dehner LP; Khan FM; McHugh R; Levitt SH
    Cancer; 1978 Sep; 42(3):1185-91. PubMed ID: 100207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contamination dose from photoneutron processes in bodily tissues during therapeutic radiation delivery.
    Difilippo F; Papiez L; Moskvin V; Peplow D; DesRosiers C; Johnson J; Timmerman R; Randall M; Lillie R
    Med Phys; 2003 Oct; 30(10):2849-54. PubMed ID: 14596320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation dose as a risk factor for malignant melanoma following childhood cancer.
    Guérin S; Dupuy A; Anderson H; Shamsaldin A; Svahn-Tapper G; Moller T; Quiniou E; Garwicz S; Hawkins M; Avril MF; Oberlin O; Chavaudra J; de Vathaire F
    Eur J Cancer; 2003 Nov; 39(16):2379-86. PubMed ID: 14556931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinogenic effects of scattered dose associated with radiation therapy.
    Cumberlin RL; Dritschilo A; Mossman KL
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):623-9. PubMed ID: 2777651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.